Van Eck Associates Corp Charles River Laboratories International, Inc. Transaction History

Van Eck Associates Corp

  • $108 Billion
  • Q3 2025

A detailed history of Van Eck Associates Corp transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 38,790 shares of CRL stock, worth $6.51 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
38,790
Previous 44,526 12.88%
Holding current value
$6.51 Million
Previous $6.76 Million 10.17%
% of portfolio
0.01%
Previous 0.01%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$145.57 - $178.99 $834,989 - $1.03 Million
-5,736 Reduced 12.88%
38,790 $6.07 Million
Q2 2025

Aug 14, 2025
SELL
$99.75 - $151.89 $171,969 - $261,858
-1,724 Reduced 3.73%
44,526 $6.76 Million
Q1 2025

May 15, 2025
SELL
$150.52 - $190.14 $320,607 - $404,998
-2,130 Reduced 4.4%
46,250 $6.96 Million
Q4 2024

Jan 29, 2025
SELL
$178.58 - $220.69 $516,631 - $638,456
-2,893 Reduced 5.64%
48,380 $8.93 Million
Q3 2024

Oct 29, 2024
SELL
$187.96 - $245.29 $1.25 Million - $1.63 Million
-6,633 Reduced 11.45%
51,273 $9.57 Million
Q2 2024

Jul 31, 2024
BUY
$206.39 - $268.73 $468,298 - $609,748
2,269 Added 4.08%
57,906 $12 Million
Q1 2024

Apr 30, 2024
SELL
$203.52 - $273.43 $415,587 - $558,344
-2,042 Reduced 3.54%
55,637 $15.1 Million
Q4 2023

Feb 05, 2024
SELL
$164.52 - $238.84 $891,369 - $1.29 Million
-5,418 Reduced 8.59%
57,679 $13.6 Million
Q3 2023

Nov 08, 2023
BUY
$194.44 - $217.61 $1.45 Million - $1.62 Million
7,461 Added 13.41%
63,097 $12.4 Million
Q2 2023

Aug 03, 2023
BUY
$183.71 - $210.25 $438,515 - $501,866
2,387 Added 4.48%
55,636 $11.7 Million
Q1 2023

May 03, 2023
SELL
$191.89 - $259.92 $1.53 Million - $2.07 Million
-7,950 Reduced 12.99%
53,249 $10.7 Million
Q4 2022

Feb 08, 2023
BUY
$197.11 - $250.07 $3.13 Million - $3.97 Million
15,893 Added 35.08%
61,199 $13.3 Million
Q3 2022

Oct 27, 2022
SELL
$182.44 - $250.54 $2.88 Million - $3.95 Million
-15,778 Reduced 25.83%
45,306 $8.92 Million
Q2 2022

Aug 03, 2022
BUY
$204.13 - $302.4 $878,779 - $1.3 Million
4,305 Added 7.58%
61,084 $13.1 Million
Q1 2022

May 10, 2022
BUY
$255.51 - $362.11 $64,644 - $91,613
253 Added 0.45%
56,779 $16.1 Million
Q4 2021

Jan 26, 2022
SELL
$351.38 - $448.68 $1.43 Million - $1.83 Million
-4,076 Reduced 6.73%
56,526 $21.3 Million
Q3 2021

Nov 03, 2021
SELL
$372.64 - $458.3 $4.25 Million - $5.22 Million
-11,399 Reduced 15.83%
60,602 $25 Million
Q2 2021

Aug 10, 2021
BUY
$294.17 - $371.65 $1.69 Million - $2.14 Million
5,757 Added 8.69%
72,001 $26.6 Million
Q1 2021

May 13, 2021
SELL
$249.67 - $299.48 $1.31 Million - $1.57 Million
-5,255 Reduced 7.35%
66,244 $19.2 Million
Q4 2020

Feb 09, 2021
BUY
$222.0 - $252.62 $1.54 Million - $1.75 Million
6,915 Added 10.71%
71,499 $17.9 Million
Q3 2020

Nov 12, 2020
SELL
$175.56 - $226.45 $2.37 Million - $3.06 Million
-13,522 Reduced 17.31%
64,584 $14.6 Million
Q2 2020

Aug 10, 2020
BUY
$118.84 - $189.72 $2.09 Million - $3.33 Million
17,569 Added 29.02%
78,106 $13.6 Million
Q1 2020

May 12, 2020
SELL
$98.9 - $178.34 $1.53 Million - $2.76 Million
-15,455 Reduced 20.34%
60,537 $7.64 Million
Q4 2019

Feb 13, 2020
BUY
$126.05 - $152.76 $128,066 - $155,204
1,016 Added 1.36%
75,992 $11.6 Million
Q3 2019

Nov 08, 2019
BUY
$125.07 - $143.67 $226,876 - $260,617
1,814 Added 2.48%
74,976 $9.93 Million
Q2 2019

Aug 07, 2019
SELL
$123.4 - $148.55 $1.7 Million - $2.05 Million
-13,803 Reduced 15.87%
73,162 $10.4 Million
Q1 2019

May 13, 2019
SELL
$104.82 - $146.73 $1.46 Million - $2.05 Million
-13,974 Reduced 13.84%
86,965 $12.6 Million
Q4 2018

Feb 12, 2019
BUY
$105.09 - $137.23 $712,720 - $930,693
6,782 Added 7.2%
100,939 $11.4 Million
Q3 2018

Nov 13, 2018
BUY
$112.11 - $134.54 $53,924 - $64,713
481 Added 0.51%
94,157 $12.7 Million
Q2 2018

Aug 13, 2018
BUY
$102.37 - $117.25 $1.36 Million - $1.56 Million
13,291 Added 16.53%
93,676 $10.5 Million
Q1 2018

May 11, 2018
SELL
$98.19 - $115.2 $1.88 Million - $2.21 Million
-19,168 Reduced 19.25%
80,385 $8.58 Million
Q4 2017

Feb 12, 2018
SELL
$100.43 - $118.09 $5.42 Million - $6.37 Million
-53,924 Reduced 35.13%
99,553 $10.9 Million
Q3 2017

Nov 09, 2017
BUY
$96.72 - $109.26 $502,460 - $567,605
5,195 Added 3.5%
153,477 $16.6 Million
Q2 2017

Aug 11, 2017
BUY
N/A
148,282
148,282 $15 Million

Others Institutions Holding CRL

# of Institutions
646
Shares Held
51.6M
Call Options Held
194K
Put Options Held
174K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email